(Q38011036)

26 August 2017

1 reference

title

Interspecies comparisons in toxicology: the utility and futility of plasma concentrations of the test substance (English)

1 reference

26 August 2017

Monro AM

1

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 October 1990

1 reference

Regulatory Toxicology and Pharmacology

26 August 2017

published in

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

137-160

1 reference

Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

The biological basis and measurement of thresholds

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Saturable metabolism and its relationship to toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Domestication of chemistry by design of safer chemicals: structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Pharmacokinetics for regulatory risk analysis: the case of 1,1,1-trichloroethane (methyl chloroform).

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

TOXICOLOGY AND THE BIOMEDICAL SCIENCES.

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Pharmacokinetics and toxicity testing

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Dose-Dependent Pharmacokinetics: Emphasis on Phase I Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Induction of peroxisomal beta-oxidation in the rat liver in vivo and in vitro by tetrazole-substituted acetophenones: structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Defective oxidation of drugs: pharmacokinetic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Estimation of exposure of man to substances reacting covalently with macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Toxic effects of chemicals: difficulties in extrapolating data from animals to man.

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Resolution of dose-response toxicity data for chemicals requiring metabolic activation: Example?Vinyl chloride*1

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Physiologically Based Pharmacokinetic Modeling: Principles and Applications

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

The problem of chemically reactive metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Enzymatic activation of chemicals to toxic metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Oxygen toxicity, oxygen radicals, transition metals and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical Significance

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

The Delayed Neuropathy Caused by Some Organophosphorus Esters: Mechanism and Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Pharmacokinetic considerations in toxicity testing

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Oxidative stress in chemical toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Tissue drug residues and their toxicological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Chemical nature of reactive intermediates as determinant of toxicologic responses

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Histamine receptors in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Mechanisms of chemical toxicity--a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Pharmacology and toxicology of the monovalent carboxylic ionophores

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Nonlinear pharmacokinetics relative to toxicity and use of toxicological data

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Physiologic pharmacokinetic models: relevance, experience, and future trends

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Chemically induced proliferation of peroxisomes: implications for risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Species differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Plasma and Tissue Binding Considerations in Drug Disposition

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

Motor end-plate differences as a determining factor in the mode of action of neuromuscular blocking substances

1 reference

https://api.crossref.org/works/10.1016%2FS0273-2300%2805%2980055-8

7 January 2021

10.1016/S0273-2300(05)80055-8

Identifiers

DOI

1 reference

26 August 2017

1 reference